The insufflator, nti part number 7-650-00; serial number (b)(4) arrived at nti on (b)(6) 2019.The device and complaint were evaluated under nti capa (b)(4).This device was tested through the final quality control testing procedure for the device on (b)(6) 2019.The device functioned normally even though it exhibited a slightly higher low flow rate during fqc testing.The higher low flow rate most likely would not cause the over-insufflation given that the flow rate was set at 50 lpm.The complaint description was evaluated further by engineering.The device was tested using a pressure chamber with two trocars.When the trocar with the tap attached was removed this caused a leak and the gas flow increased to keep up with the leak with no occurrence of over-pressure.The trocar was then re-inserted back into the pressure chamber and the set pressure was re-established.The sequence of test was repeated many times, but the over-insufflation situation could not be duplicated.When the trocar was re-inserted back into the chamber, sometimes an overshoot (up to 22mmhg) occurred but quickly returned to the 15mmhg setting.The device was determined to be functioning as expected.Since the event could not be duplicated and occurred at the end of the procedure when the trocars were removed without first stopping the insufflator, the likelihood of this occurring again is low.A device history record review (dhr) was conducted for the device under complaint (b)(4).The device history record for device serial number (b)(4) from (b)(6) of 2019 (nti manufacturing order (b)(4)) was reviewed and the device passed all testing.During production, the unit required replacement of the valve board.The unit was able to be successfully calibrated.The unit was then recalibrated using a different flow meter successfully (after a potential issue was identified with the flow meter used to calibrate the device initially).The device was put through fqc testing with a warmer on the regulator.This change (reference nti engineering change (b)(4)) was implemented to align final quality release with manufacturing calibration.The device passed all fqc and production inspections and testing and there were no critical issues noted in the documentation associated with (b)(4).Any additional findings will be updated via a follow-up report.(b)(4).
|
On (b)(6) 2019, northgate technologies logged a complaint of an issue with an insufflator which reported the following, "the nebulae i system over-insufflated.At the end of the case [the surgeon was] pulling out some trocars.One of the trocar has the tap sensing tubing set connected.At that time, the insufflator recorded a pressure that is greater than 15 mmhg.The flow was set to 50 lpm." additional information was received on (b)(6) 2019 indicating, "the procedure went fine until the end when the insufflator continued to pump high pressure into the abdomen when other connections were removed.This affected the cardiac output of the patient and anesthesia had to medicate the patient.Fortunately, patient is doing fine.Additionally, [the surgeon] was concerned that it could affect kidney functions.[the rep] believe[s] the system was not turned off and caused this.[the surgeon] felt that this is a patient safety issue.".
|